questionsmedicales.fr
Infection
Infections bactériennes et mycoses
Infections bactériennes
Infections bactériennes à Gram négatif
Infections à Moraxellaceae
Infections à Acinetobacter
Infections à Acinetobacter : Questions médicales fréquentes
Diagnostic
5
Tests de sensibilité
Culture bactérienne
Infections bactériennes
Diagnostic
Échantillons biologiques
Acinetobacter
Symptômes
5
Symptômes
Infections bactériennes
Infections pulmonaires
Symptômes respiratoires
Infections urinaires
Acinetobacter
Infections cutanées
Acinetobacter
Prévention
5
Isolement
Infections nosocomiales
Soins des plaies
Prévention
Traitements
5
Antibiotiques
Acinetobacter
Soins intensifs
Infections bactériennes
Hospitalisation
Acinetobacter
Thérapie par phages
Acinetobacter
Résistance aux antibiotiques
Acinetobacter
Complications
5
Complications
Infections bactériennes
Résistance aux antibiotiques
Acinetobacter
Infections secondaires
Acinetobacter
Immunodépression
Complications
Facteurs de risque
5
Facteurs de risque
Acinetobacter
Ventilation mécanique
Infections nosocomiales
Âge avancé
Facteurs de risque
Immunodépression
Acinetobacter
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Infections à Acinetobacter : Questions médicales les plus fréquentes",
"headline": "Infections à Acinetobacter : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Infections à Acinetobacter : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2026-02-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Infections à Acinetobacter"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Infections à Moraxellaceae",
"url": "https://questionsmedicales.fr/mesh/D045828",
"about": {
"@type": "MedicalCondition",
"name": "Infections à Moraxellaceae",
"code": {
"@type": "MedicalCode",
"code": "D045828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.400.560"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Infections à Acinetobacter",
"alternateName": "Acinetobacter Infections",
"code": {
"@type": "MedicalCode",
"code": "D000151",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": "The Saudi Critical Care Trial Group, Riyadh, Saudi Arabia."
}
},
{
"@type": "Person",
"name": "Greg Harris",
"url": "https://questionsmedicales.fr/author/Greg%20Harris",
"affiliation": {
"@type": "Organization",
"name": "Human Health Therapeutics Research Center, National Research Council Canada, 100 Sussex Drive, Ottawa, Ontario, K1A 0R6, Canada."
}
},
{
"@type": "Person",
"name": "H Howard Xu",
"url": "https://questionsmedicales.fr/author/H%20Howard%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Sciences, California State University, Los Angeles, Los Angeles, CA, 90032, USA."
}
},
{
"@type": "Person",
"name": "Wangxue Chen",
"url": "https://questionsmedicales.fr/author/Wangxue%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Human Health Therapeutics Research Center, National Research Council Canada, 100 Sussex Drive, Ottawa, Ontario, K1A 0R6, Canada. wangxue.chen@nrc.gc.ca."
}
},
{
"@type": "Person",
"name": "Lauren D Palmer",
"url": "https://questionsmedicales.fr/author/Lauren%20D%20Palmer",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, University of Illinois Chicago, Chicago, Illinois, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Acinetobacter Metabolism in Infection and Antimicrobial Resistance.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37191522",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/iai.00433-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "How to treat severe Acinetobacter baumannii infections.",
"datePublished": "2023-09-26",
"url": "https://questionsmedicales.fr/article/37930071",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/QCO.0000000000000974"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genome sequence of a tigecycline-resistant Acinetobacter seifertii recovered in human bloodstream infection in China.",
"datePublished": "2023-06-24",
"url": "https://questionsmedicales.fr/article/37364734",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jgar.2023.06.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Treatment of Intracranial Infection by Extensively Drug-Resistant Acinetobacter Baumannii After Craniocerebral Surgery.",
"datePublished": "2024-10-01",
"url": "https://questionsmedicales.fr/article/39418529",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/SCS.0000000000010542"
}
},
{
"@type": "ScholarlyArticle",
"name": "Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study.",
"datePublished": "2023-06-14",
"url": "https://questionsmedicales.fr/article/37349243",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jiph.2023.06.009"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Infections bactériennes et mycoses",
"item": "https://questionsmedicales.fr/mesh/D001423"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections bactériennes",
"item": "https://questionsmedicales.fr/mesh/D001424"
},
{
"@type": "ListItem",
"position": 5,
"name": "Infections bactériennes à Gram négatif",
"item": "https://questionsmedicales.fr/mesh/D016905"
},
{
"@type": "ListItem",
"position": 6,
"name": "Infections à Moraxellaceae",
"item": "https://questionsmedicales.fr/mesh/D045828"
},
{
"@type": "ListItem",
"position": 7,
"name": "Infections à Acinetobacter",
"item": "https://questionsmedicales.fr/mesh/D000151"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Infections à Acinetobacter - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Infections à Acinetobacter",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Infections à Acinetobacter",
"description": "Comment diagnostique-t-on une infection à Acinetobacter ?\nQuels tests sont utilisés pour identifier Acinetobacter ?\nLes infections à Acinetobacter sont-elles faciles à diagnostiquer ?\nQuels échantillons sont prélevés pour le diagnostic ?\nLes tests PCR sont-ils utilisés pour Acinetobacter ?",
"url": "https://questionsmedicales.fr/mesh/D000151#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Infections à Acinetobacter",
"description": "Quels sont les symptômes d'une infection à Acinetobacter ?\nLes infections à Acinetobacter causent-elles de la fièvre ?\nPeut-on avoir des symptômes respiratoires ?\nLes infections urinaires à Acinetobacter sont-elles fréquentes ?\nY a-t-il des symptômes cutanés associés ?",
"url": "https://questionsmedicales.fr/mesh/D000151#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Infections à Acinetobacter",
"description": "Comment prévenir les infections à Acinetobacter ?\nLes mesures d'isolement sont-elles nécessaires ?\nLes vaccinations aident-elles contre Acinetobacter ?\nLes soins des plaies peuvent-ils prévenir les infections ?\nLes antibiotiques préventifs sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D000151#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Infections à Acinetobacter",
"description": "Quels antibiotiques sont efficaces contre Acinetobacter ?\nComment traite-t-on une infection sévère à Acinetobacter ?\nLes infections à Acinetobacter nécessitent-elles une hospitalisation ?\nY a-t-il des traitements alternatifs ?\nLes infections à Acinetobacter sont-elles résistantes aux traitements ?",
"url": "https://questionsmedicales.fr/mesh/D000151#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Infections à Acinetobacter",
"description": "Quelles sont les complications possibles des infections à Acinetobacter ?\nLes infections à Acinetobacter peuvent-elles être mortelles ?\nY a-t-il des risques de résistance accrue ?\nLes infections à Acinetobacter peuvent-elles causer des infections secondaires ?\nLes complications sont-elles plus fréquentes chez certains patients ?",
"url": "https://questionsmedicales.fr/mesh/D000151#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Infections à Acinetobacter",
"description": "Quels sont les principaux facteurs de risque d'infection à Acinetobacter ?\nLes patients diabétiques sont-ils plus à risque ?\nLes patients sous ventilation mécanique sont-ils à risque ?\nL'âge avancé est-il un facteur de risque ?\nLes patients immunodéprimés sont-ils plus susceptibles ?",
"url": "https://questionsmedicales.fr/mesh/D000151#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection à Acinetobacter ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par culture bactérienne à partir d'échantillons cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Acinetobacter ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de sensibilité aux antibiotiques et des cultures spécifiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Les infections à Acinetobacter sont-elles faciles à diagnostiquer ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être difficiles à diagnostiquer en raison de leur similitude avec d'autres infections."
}
},
{
"@type": "Question",
"name": "Quels échantillons sont prélevés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échantillons de sang, d'urine, de pus ou de sécrétions respiratoires peuvent être prélevés."
}
},
{
"@type": "Question",
"name": "Les tests PCR sont-ils utilisés pour Acinetobacter ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR peut être utilisée pour détecter rapidement des souches spécifiques d'Acinetobacter."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection à Acinetobacter ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon le site d'infection, incluant fièvre, douleur et inflammation."
}
},
{
"@type": "Question",
"name": "Les infections à Acinetobacter causent-elles de la fièvre ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre est un symptôme courant d'infections à Acinetobacter."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes respiratoires ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections pulmonaires peuvent provoquer toux, dyspnée et douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Les infections urinaires à Acinetobacter sont-elles fréquentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Acinetobacter peut causer des infections urinaires, entraînant douleur et brûlures."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections cutanées peuvent provoquer rougeurs, gonflements et pus."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections à Acinetobacter ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène, le lavage des mains et la désinfection des surfaces sont essentiels."
}
},
{
"@type": "Question",
"name": "Les mesures d'isolement sont-elles nécessaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans les hôpitaux, les patients infectés peuvent nécessiter un isolement pour éviter la propagation."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles contre Acinetobacter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin spécifique contre Acinetobacter."
}
},
{
"@type": "Question",
"name": "Les soins des plaies peuvent-ils prévenir les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon soin des plaies peut réduire le risque d'infections à Acinetobacter."
}
},
{
"@type": "Question",
"name": "Les antibiotiques préventifs sont-ils recommandés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation d'antibiotiques préventifs n'est généralement pas recommandée sans indication."
}
},
{
"@type": "Question",
"name": "Quels antibiotiques sont efficaces contre Acinetobacter ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les carbapénèmes et les polymyxines sont souvent utilisés, mais la résistance est fréquente."
}
},
{
"@type": "Question",
"name": "Comment traite-t-on une infection sévère à Acinetobacter ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement combiné d'antibiotiques et des soins intensifs peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Les infections à Acinetobacter nécessitent-elles une hospitalisation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, souvent, surtout pour les cas graves ou chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux comme les thérapies par phages sont en cours d'étude."
}
},
{
"@type": "Question",
"name": "Les infections à Acinetobacter sont-elles résistantes aux traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses souches sont multirésistantes, rendant le traitement difficile."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des infections à Acinetobacter ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent septicémie, pneumonie et infections des plaies."
}
},
{
"@type": "Question",
"name": "Les infections à Acinetobacter peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être graves et potentiellement mortelles, surtout chez les patients fragiles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de résistance accrue ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements inappropriés peuvent favoriser le développement de souches résistantes."
}
},
{
"@type": "Question",
"name": "Les infections à Acinetobacter peuvent-elles causer des infections secondaires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent affaiblir le système immunitaire et entraîner des infections secondaires."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus fréquentes chez certains patients ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients immunodéprimés ou hospitalisés sont plus à risque de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection à Acinetobacter ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hospitalisation prolongée, les soins intensifs et l'utilisation d'antibiotiques."
}
},
{
"@type": "Question",
"name": "Les patients diabétiques sont-ils plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut affaiblir le système immunitaire, augmentant le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les patients sous ventilation mécanique sont-ils à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont particulièrement vulnérables aux infections à Acinetobacter."
}
},
{
"@type": "Question",
"name": "L'âge avancé est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un système immunitaire souvent affaibli, augmentant le risque."
}
},
{
"@type": "Question",
"name": "Les patients immunodéprimés sont-ils plus susceptibles ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients immunodéprimés courent un risque accru d'infections à Acinetobacter."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/02/2026
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
The Saudi Critical Care Trial Group, Riyadh, Saudi Arabia.
Publications dans "Infections à Acinetobacter" :
3 publications dans cette catégorie
Affiliations :
Human Health Therapeutics Research Center, National Research Council Canada, 100 Sussex Drive, Ottawa, Ontario, K1A 0R6, Canada.
Publications dans "Infections à Acinetobacter" :
3 publications dans cette catégorie
Affiliations :
Department of Biological Sciences, California State University, Los Angeles, Los Angeles, CA, 90032, USA.
Publications dans "Infections à Acinetobacter" :
3 publications dans cette catégorie
Affiliations :
Human Health Therapeutics Research Center, National Research Council Canada, 100 Sussex Drive, Ottawa, Ontario, K1A 0R6, Canada. wangxue.chen@nrc.gc.ca.
Department of Biology, Brock University, St. Catharines, Ontario, L2S 3A1, Canada. wangxue.chen@nrc.gc.ca.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, University of Illinois Chicago, Chicago, Illinois, USA.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Keck School of Medicine at the University of Southern California (USC), Los Angeles, California, United States of America.
Department of Molecular Microbiology and Immunology, Keck School of Medicine at the University of Southern California (USC), Los Angeles, California, United States of America.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Keck School of Medicine at the University of Southern California (USC), Los Angeles, California, United States of America.
Department of Molecular Microbiology and Immunology, Keck School of Medicine at the University of Southern California (USC), Los Angeles, California, United States of America.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Keck School of Medicine at the University of Southern California (USC), Los Angeles, California, United States of America.
Department of Molecular Microbiology and Immunology, Keck School of Medicine at the University of Southern California (USC), Los Angeles, California, United States of America.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Keck School of Medicine at the University of Southern California (USC), Los Angeles, California, United States of America.
Department of Molecular Microbiology and Immunology, Keck School of Medicine at the University of Southern California (USC), Los Angeles, California, United States of America.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Wound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA. daniel.v.zurawski.civ@mail.mil.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Wound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Clinica Malattie Infettive, IRCCS Ospedale Policlinico, Genoa.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Clinica Malattie Infettive, IRCCS Ospedale Policlinico, Genoa.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Department of Pulmonology, University of Udine and Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Clinica Malattie Infettive, IRCCS Ospedale Policlinico, Genoa.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria-ASST-Sette Laghi, Varese, Italy.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria-ASST-Sette Laghi, Varese, Italy.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, School of Medicine, Koç University, Istanbul, Turkey. Electronic address: oergonul@ku.edu.tr.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, School of Medicine, Koç University, Istanbul, Turkey.
Publications dans "Infections à Acinetobacter" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, TN, USA.
Publications dans "Infections à Acinetobacter" :
Acinetobacter infections have high rates of mortality due to an increasing incidence of infections by multidrug-resistant (MDR) and extensively-drug-resistant (XDR) strains. Therefore, new therapeutic...
To update the management of severe Acinetobacter baumannii infections (ABI), particularly those caused by multi-resistant isolates....
The in vitro activity of the various antimicrobial agents potentially helpful in treating ABI is highly variable and has progressively decreased for many of them, limiting current therapeutic options....
The apparent limitations in treating infections caused by this bacterium, the rapid development of resistance, and the serious underlying situation in most cases invite the search for alternatives to ...
The phylogenetic characteristics of Acinetobacter seifertii clinical strain are not well-studied. Here, we reported one tigecycline-resistant ST1612Pasteur A. seifertii isolated from bloodstream infec...
Antimicrobial susceptibility tests were conducted via broth microdilution. Whole-genome sequencing (WGS) was performed and annotation was conducted using rapid annotations subsystems technology (RAST)...
The draft genome sequence of A. seifertii ASTCM strain is made up of 109 contigs with a total length of 4,074,640 bp. Based on the RAST results, 3923 genes that belonged to 310 subsystems were annotat...
In summary, we reported a tigecycline-resistant ST1612Pasteur A. seifertii in China. Early detection is recommended to prevent their further spread in clinical settings....
The clinical outcome of intracranial infections caused by extensively drug-resistant Acinetobacter baumannii (XDRAB) remains unsatisfactory, even when treated with combined antibiotic therapy. This st...
The clinical data of a patient with an XDRAB intracranial infection after a craniocerebral operation were retrospectively analyzed, and the treatment approach for XDRAB intracranial infection was exam...
Upon the occurrence of XDRAB intracranial infection after craniocerebral surgery, the patient was given an intravenous injection of polymyxin B+ tigecycline + amikacin, while intrathecal injection of ...
Polymyxin B+ tigecycline + amikacin intravenous and intrathecal polymyxin B can benefit XDRAB intracranial infected patients after craniofacial surgery....
No clear evidence supports the use of cefiderocol as first line treatment in A. baumannii infections....
We conducted an observational retrospective/prospective multicenter study including all patients> 18 years with carbapenem-resistant A. baumannii (CRAB) infections treated with cefiderocol, from June ...
Thirty-eight patients with forty episodes of infection were included [mean age 65 years (SD+16.3), 75% males, 90% with hospital-acquired infections and 70% showing sepsis or septic shock]. The most co...
The findings of this study reinforce the effectiveness of cefiderocol in CRAB infections, also as monotherapy. However, prospective multicenter studies with larger sample sizes and a control group tre...
The global threat of Carbapenem-resistant Acinetobacter baumannii (CRAB) has intensified as resistance to carbapenems continues to rise in recent decades. We aimed to explore risk factors, molecular e...
The clinical data of 110 patients infected with A. baumannii from December 2021 to December 2022 were retrospectively analyzed. Patients were divided into a carbapenem-resistance group (55 patients) a...
Among the total 110 patients, the rate of poor prognosis in the CRAB group was 43.6% (24/55). Mechanical ventilation (odds ratio [OR] = 5.364, 95% confidence interval [CI] 1.462-19.679, P = 0.011) and...
Mortality was significantly higher in patients infected with CRAB than with CSAB. Mechanical ventilation and puncture were independent risk factors in predicting CRAB infections. The distribution of C...
Acinetobacter baumannii is a Gram-negative opportunistic bacterium responsible for nosocomial and community-acquired infections. This pathogen is globally disseminated and associated with high levels ...
Acinetobacter baumannii infection presents a high mortality rate and few therapeutic options. This study aimed to evaluate clinical-microbiological characteristics and prognosis factors of patients di...
Acinetobacter baumannii and Acinetobacter nosocomialis are the imperious pathogens in the intensive care units. We aimed to explore the genomic features of these pathogens to understand the factors in...
The type VI secretion system (T6SS) has been regarded as a late-model virulence factor widely distributed in Acinetobacter baumannii (A. baumannii). This study aimed to elucidate the clinical manifest...